SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-008927
Filing Date
2019-05-10
Accepted
2019-05-10 14:25:09
Documents
43
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 537043
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 14294
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 14409
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 7665
  Complete submission text file 0001140361-19-008927.txt   3228060

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bstc-20190331.xml EX-101.INS 571055
6 XBRL TAXONOMY EXTENSION SCHEMA bstc-20190331.xsd EX-101.SCH 26713
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20190331_cal.xml EX-101.CAL 32601
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20190331_def.xml EX-101.DEF 151236
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20190331_lab.xml EX-101.LAB 419269
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20190331_pre.xml EX-101.PRE 248160
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 19814265
SIC: 2834 Pharmaceutical Preparations